Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Dec 2025 is 13.66% vs -13.19% in Sep 2025
Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 49.88% vs -49.36% in Sep 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Dec 2025 is 54.30% vs -46.57% in Sep 2025
Interest
QoQ Growth in quarter ended Dec 2025 is 185.71% vs 0.00% in Sep 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
Compare Quarterly Results Of Jiangsu Hengrui Pharmaceuticals Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Dec 2025 is 13.66% vs -13.19% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 8.29% vs 34.26% in Dec 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Dec 2025 is 49.88% vs -49.36% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 13.72% vs 108.12% in Dec 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Dec 2025 is 54.30% vs -46.57% in Sep 2025
YoY Growth in quarter ended Dec 2025 is 19.06% vs 121.60% in Dec 2024
Quarterly - Interest
QoQ Growth in quarter ended Dec 2025 is 185.71% vs 0.00% in Sep 2025
YoY Growth in quarter ended Dec 2025 is -9.09% vs 83.33% in Dec 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Dec 2025 has improved from Sep 2025
YoY Growth in quarter ended Dec 2025 has improved from Dec 2024






